Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
deals
life sciences
national blog main
national top stories
new york blog main
new york top stories
3
×
san francisco blog main
san francisco top stories
startups
vc
acetylon pharmaceuticals
acute myeloid leukemia
alx oncology
ambys medicines
autoimmune diseases
azacitidine
berkeley lights
beta-thalassemia
biotech ipos
boston
cancer drugs
cancer immunotherapy
cd47
cell therapy
chronic kidney disease
clinical trials
constellation pharmaceuticals
dacogen
decitabine
deerfield healthcare technology acquisitions
deerfield management company
dna
epigenetics
epizyme
europe blog main
europe top stories
farydak
What
biotech
3
×
new
3
×
medicines
research
startup
aiming
aims
ambys
approach
arrival
based
big
called
companies
control
days
deadly
deal
debuted
debuts
developing
diseases
drugs
epigenetic
epigenetics
field
flagship’s
formed
future
hasn’t
industry
ipo
ipos
launch
life
liver
make
market
momentum
morning
Language
unset
Current search:
biotech
×
new
×
" new york top stories "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?